Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Current Opinion in Chemical Biology|April 26, 2003
Functional profiling of the proteome with affinity labelsDavid A Campbell, Anna Katrin Szardenings
Drug Discovery Today. Technologies|July 2, 2014
Fishing for targets: novel approaches using small molecule baitsKatrin Szardenings, Bei Li, Lifu Ma, et al.
Bioorganic & Medicinal Chemistry Letters|October 24, 2006
Synthesis and activity of a potent, specific azabicyclo[3.3.0]-octane-based DPP II inhibitorOlga Danilova, Bei Li, A Katrin Szardenings, et al.
Molecular Imaging and Biology|January 12, 2019
PET Imaging of the P2X7 Ion Channel with a Novel Tracer [18F]JNJ-64413739 in a Rat Model of NeuroinflammationTamara Berdyyeva, Chunfang Xia, Natalie Taylor, et al.
Circulation. Cardiovascular Imaging|February 7, 2015
Noninvasive molecular imaging of apoptosis in a mouse model of anthracycline-induced cardiotoxicityHelen Su, Natalia Gorodny, Luis Felipe Gomez, et al.
Biochemistry|January 11, 2007
Functional interrogation of the kinome using nucleotide acyl phosphatesMatthew P Patricelli, A Katrin Szardenings, Marek Liyanage, et al.
Journal of Alzheimer'S Disease : JAD|December 14, 2012
Early clinical PET imaging results with the novel PHF-tau radioligand [F-18]-T807David T Chien, Shadfar Bahri, A Katrin Szardenings, et al.
EJNMMI Radiopharmacy and Chemistry|August 14, 2018
Synthesis, radiosynthesis, in vitro and first in vivo evaluation of a new matrix metalloproteinase inhibitor based on γ-fluorinated α-sulfonylaminohydroxamic acidVerena Hugenberg, Malte Behrends, Stefan Wagner, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 9, 2019
Preclinical Evaluation and Nonhuman Primate Receptor Occupancy Study of 18F-JNJ-64413739, a PET Radioligand for P2X7 ReceptorsHartmuth C Kolb, Olivier Barret, Anindya Bhattacharya, et al.
Journal of Medicinal Chemistry|August 1, 2013
Inverse 1,2,3-triazole-1-yl-ethyl substituted hydroxamates as highly potent matrix metalloproteinase inhibitors: (radio)synthesis, in vitro and first in vivo evaluationVerena Hugenberg, Burkhard Riemann, Sven Hermann, et al.
Pageof 3